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Abstract 
Purpose: To identify a Shigella flexneri hemagglutinin outer membrane protein (OMP) as an adhesion 
factor and examine its ability to cross-react with the OMPs of other Shigella species. 
Methods: OMP was isolated from the bacterium S. flexneri after shaving the pili using a pili bacterial 
cutter in a solution of 0.5 % n-octyl-β-D-glucopyranoside. Hemagglutination was evaluated using mice 
erythrocytes. The molecular weight (MW) of the OMPs was profiled by SDS-PAGE. Adhesion molecules 
were identified by calculating the index of adhesion. Thereafter, antigen cross-reaction with antibodies 
was examined by Western blotting, 
Results: The S. flexneri adhesion molecule OMP has a MW of 28 kDa. An antibody against the 28 kDa 
S. flexneri OMP adhesion molecule cross-reacted with different MW OMPs from other Shigella species. 
Conclusion: This study showed that the 28 kDa S. flexneri OMP is a hemagglutinin adhesion protein, 
and antibodies against it can cross-react with the OMPs of other Shigella species. 
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INTRODUCTION 
 
Diarrhea is the fourth leading cause of 
morbidity and mortality worldwide, and 
Shigella species cause an estimated 
164.7 million cases of diarrhea annually. 
In developing countries, the 163.2 million 
cases resulted in 1.2 million deaths [1]. 
In South Jakarta, the predominant 
isolate was S. flexneri, which is often 
isolated in other developing regions, 
such as Bangladesh, Pakistan, and 
Africa [2]. S. flexneri is endemic in 
developing countries [1,3]. 
 
Shigella is a highly infectious pathogen, 
because only 10 – 100 ingested bacteria 
are sufficient to cause disease [4]. The 
success of a pathogenic bacterial 
infection requires attachment to host 
cells, tissue colonization, and cell 
invasion [5]. 
 
The initial stage of infection is adhesion 
between the bacteria and host cells. 
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Outer membrane proteins (OMPs) 
include proteins that mediate the 
attachment of bacteria to the host cell 
more closely than do pili [6,7]. A 49.8 
kDa Shigella dysenteriae hemagglutinin 
pili protein that serves as an adhesion 
protein was found previously [8]. Oral 
immunization with this 49.8 kDa S. 
dysenteriae protein can increase 
intestinal secretory IgA (s-IgA) levels, 
inhibit bacterial colonization in the colon, 
and prevent damage to colon epithelial 
cells [9]. There are two S. dysenteriae 
pili protein subunits, of 7.9 and 49.8 kDa. 
The S. dysenteriae protein prevented 
diarrhea in a mouse ligated ileal loop 
(MLIL) model [10]. 
 
The World Health Organization (WHO) 
has prioritized the development of safe, 
effective vaccines for shigellosis, and 
several candidate vaccines are being 
developed currently [1,11]. OMPs have 
been used successfully as vaccine 
antigens to prevent Lyme disease and 
pertussis based on their roles as 
adhesion molecules [11-13]. The ideal 
Shigella vaccine should be able to 
induce an immune response against all 
Shigella spp. [11]. 
 
EXPERIMENTAL 
 
Sample preparation 
 
The bacteria Shigella flexneri 4a, 
Shigella dysenteriae 2a, Shigella boydii 
serotype 10, and Shigella sonnei were 
obtained from the Yogyakarta Regional 
Health Laboratory. Culture isolates of the 
Shigella species were grown on 
MacConkey medium at 37 °C for 24 h 
and then transferred to Petri dishes 
containing Salmonella-Shigella Agar 
(SSA) medium at 37 °C for 24 h. The 
resulting bacterial cultures were 
dissolved in 10 mL phosphate-buffered 
saline (PBS) (pH 7.4), added to bottles 
containing 500 mL Brain Heart Infusion 
(BHI), and shaken in a water bath for 30 
min at 37 °C. 
 
Isolation of OMP 
 
The Shigella OMP was isolated in two 
stages. The first stage involved cutting 
the bacterial cell pili, and the second 
involved isolating the OMP from the 
bacterial cell after pili cutting, as 
described in our previous study [14]. The 
OMP was isolated according to the 
method of Evans and Evans [15]. The 
pellet from the last centrifugation step 
was resuspended in PBS (pH 7.4) until 
the volume reached 15-fold, and then n-
octyl-β-D-glucopyranoside was added at 
concentrations up to 0.5 %. The resulting 
solution was homogenized using a 
vortex and centrifuged at 12,000 rpm at 
4 °C for 15 min. This treatment was 
repeated three times to give a 
supernatant rich in OMP. 
 
Purification of Shigella spp. OMP 
 
The molecular weight of the OMP was 
determined using sodium dodecyl 
sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) [16]. The 
OMP was purified by electroelution [12]. 
The elution product was dialyzed for 24 
h in a glass beaker with sterile PBS and 
stirred at 4 °C for 24 h. The obtained 
protein was precipitated by centrifugation 
at 12,000 rpm for 15 min at 4 °C. 
 
Hemagglutination test 
 
The hemagglutination test was 
performed according to the method of 
Hanne and Finkelstein with modifications 
[14]. First, 50 µL PBS were placed in the 
wells of a Microplate V, and 50 µL serial 
dilutions of the sample were added. 
Then, 50 µL 0.5 % mice erythrocyte 
suspension were added to each well, 
and the plate was shaken gently for 1 
min on a plate rotator. The 
hemagglutination titer was the lowest 
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dilution causing agglutination of the red 
blood cells. 
 
Isolation of mouse enterocytes 
 
Mice enterocytes were isolated using the 
Weisser method [17]. The mice were 
anesthetized using chloroform, their 
stomachs opened, and the small 
intestines removed. The small intestine 
was cut into small pieces and washed 
several times until clean using a solution 
of PBS containing 1 mM dithiothreitol 
(DTT) at 4 °C. Then, the intestinal tissue 
was added to a solution containing 1.5 
mM KCl, 9.6 mM NaCl, 27 mM Na-
citrate, 8 mM KH2PO4, and 5.6 mM 
Na2HPO4 at pH 7.4. The solution was 
incubated on a shaking incubator at 37 
°C for 15 min. The supernatant was 
discarded and the tissue was transferred 
to a solution containing 1.5 mM EDTA 
and 0.5 mM DTT. The liquid was shaken 
vigorously for 15 min at 37 °C, and the 
supernatant was discarded. The tissue 
was washed with PBS and then 
centrifuged at 1500 rpm at 4 °C for 5 
min; this was repeated at least three 
times until the supernatant was clear. 
Enterocytes were obtained after 
centrifugation at 1500 rpm for 5 min and 
resuspended in PBS. For the adhesion 
test, 106 enterocytes/mL were used. 
 
Adhesion test 
 
The adhesion test was performed 
according to the method of Nagayama et 
al. with modifications [14]. S. flexneri 
was cultured in BHI liquid for 24 h at 37 
°C and then centrifuged at 6000 rpm at 4 
°C for 10 min. The pellet was 
resuspended in PBS containing 1 % 
bovine serum albumin. The bacterial 
count was set at 108/mL using a 
spectrophotometer at a wavelength of 
600 nm. Then, 0, 6.25, 12.5, 25, 50, or 
100 µg of OMP was added to 300 µg of 
the enterocyte suspension and rocked 
gently on a shaking water bath at 37 °C 
for 30 min. 
Finally, 300 µg of the bacterial 
suspension (108/mL) were added to 
each mixture, incubated on a shaking 
incubator for 30 min at 37 °C, and then 
centrifuged at 1500 rpm at 4 °C for 3 
min. The pellet was washed twice with 
PBS. A sample was smeared on a glass 
slide and subjected to Gram staining. 
 
Immunization of mice with S. flexneri 
OMP 
 
The study used 6–8-week-old male 
BALB/C mice. The antigen used was the 
purified 28 kDa S. flexneri hemagglutinin 
adhesion OMP. Mice were acclimatized 
for 7 days before immunization. After 
acclimatization, the mice were injected 
intraperitoneally with 100 µg OMP that 
had been emulsified with 0.1 mL 
complete Freund’s adjuvant [18]. 
 
Isolation of polyclonal antibodies 
 
Blood was collected from the hearts of 
the mice, placed in an Eppendorf tube, 
which was left tilted for 30 min, and then 
centrifuged at 10,000 rpm for 5 min. The 
supernatant serum was stored at –20 °C 
[8]. 
 
Antigen/antibody cross-reactions 
 
The cross-reaction of Shigella spp. OMP 
antigen with antibody against the S. 
flexneri 28 kDa OMP was examined by 
Western blotting. Before performing the 
antigen antibody response test, the 
checkerboard test was necessary to 
determine the effectiveness of the 
antigen and antibody reactions to be 
evaluated. The checkerboard test uses a 
dot blot method and reacts the S. 
flexneri 28 kDa OMP antigen with 
serially diluted antibodies. The antigen 
was diluted 1/5 to 1/10240, and the 
antibody was diluted 1/100 to 1/2800. 
The results reveal a color gradation that 
can be analyzed using Corel Photo-Paint 
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to determine the mean value [19]. 
Western blotting was performed using 
the method of Towbin et al [20]. 
 
Statistical analysis 
 
The data were analyzed using SPSS 23. 
One-way analysis of variance with 
Tukey’s post hoc test was used to 
determine significant differences in the 
mean index of adhesion among the 
sample groups. Pearson’s correlation 
test was used to determine correlations 
between the sample doses and adhesion 
index. Significance level was set at p ˂ 
0.05. 
RESULTS 
 
OMP Shigella spp profiling 
 
Figure 1 shows the molecular weights of 
the four Shigella species OMPs 
determined using SDS-PAGE. The 
profiles of the Shigella spp. OMPs were 
identical. There were various Shigella 
spp. OMPs, including OMPX, OMPA, 
OMPT, OMPLA, TOLC, α-hemolysin, 
porin OMP32, FhuA, and FEPA [5]. 
 
 
Figure 1: The results of 12.5% SDS-PAGE of 
Shigella OMPs. Note: Lane 1, S. boydii OMP; 
lane 2, S. dysenteriae OMP; lane 3, S. flexneri 
OMP; lane 4, S. sonnei OMP; lane 5, marker 
 
Hemagglutination  
 
The S. flexneri OMP bands with 
molecular weights of 28, 36, 42, 52, and 
72 kDa were identified as candidate 
adhesion proteins. These five protein 
bands were excised, collected, and 
purified by electro elution and dialysis for 
the hemagglutination test. The 
hemagglutination test results shown in 
Figure 2 indicated that the 28 kDa OMP 
had the highest hemagglutination titer 
(1/32), and thus it was selected for the 
adhesion tests. 
 
Adhesion  
 
The adhesion test was conducted using 
0 (control), 6.25, 12.5, 25, 50, and 100 
µg of the 28 kDa S. flexneri OMP (Figure 
3). The adhesion index was calculated 
by counting the number of bacteria 
attached to 100 enterocytes. The result 
is shown in Table 1, which shows that 
the number of S. flexneri attached to 
mouse enterocytes decreased with 
increasing OMP dose. There was a 
significant and strong negative 
correlation between the dose and 
adhesion index (p=0.000). This proved 
that OMP inhibited the attachment of S. 
flexneri to enterocytes. 
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Figure 2: The results of the hemagglutination assay using mice erythrocytes and various molecular weight 
fractions of S. flexneri OMPs. Note: Lane C, negative control containing erythrocytes and PBS; no clumping of 
the erythrocytes was observed; lane 1, 72 kDa OMP; lane 2, 52 kDa OMP; lane 3, 42 kDa OMP; lane 4, 36 kDa 
OMP; lane 5, 28 kDa OMP 
 
 
Figure 3: Adhesion test using the 28 kDa S. flexneri OMP and mouse enterocytes 
Black arrow (        ), enterocytes; dotted arrow (        ), S. flexneri cells. Gram staining, 1000× magnification 
 
Table 1: Correlation of various doses of OMP S. flexneri with adhesion index (n = 4) 
 
Doses (µg) Mean ± SD P-value Pearson 
correlation 
0 (control) 1427.8±265.8   
6.25 1244±69.4   
12.5 785.5±148.1 0.000˂α -0.786 
25 596.0±20.2   
50 437.8±28.2   
100 332.3±31.8    
 
Antigen/antibody cross-reaction 
 
In the checkerboard test, the S. flexneri 
OMP antigen diluted 1/320 and 
antibodies against the 28 kDa S. flexneri 
OMP diluted 1/400 showed the lowest 
density (data not shown). In this zone, 
there is a balanced antigen to antibody 
ratio. In Western blotting, antibodies 
against the 28 kDa S. flexneri OMP 
diluted 1/400 reacted with Shigella spp. 
OMP. 
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In Figure 4, lane 1 represents the 28 kDa 
S. flexneri OMP reacting with the 
antibody against the 28 kDa S. flexneri 
OMP, demonstrating that the 28 kDa S. 
flexneri OMP is an antigen capable of 
stimulating an antibody response. OMPs 
from other Shigella spp. (Figure 4, lanes 
2 to 4) also reacted with the 28 kDa S. 
flexneri OMP antibody. 
 
 
Figure 4: Western blotting of the Shigella spp. 
OMPs using an antibody against the 28 kDa S. 
flexneri OMP. Note: Lane 1, S. flexneri OMP; 
lane 2, S. dysenteriae OMP; lane 3, S. sonnei 
OMP; lane 4, S. boydii OMP; lane 5, marker 
 
DISCUSSION 
 
Shigellosis is caused by four Shigella species: S. 
flexneri, S. dysenteriae, S. boydii, and S. sonnei 
[4]. Shigella spp. OMP was isolated after shaving 
the bacteria pili using a pili bacterial cutter. The 
profiles of the Shigella spp. OMPs on SDS-
PAGE gels were identical, and their calculated 
molecular weights were similar. The number of 
OMP bands observed on SDS-PAGE gels 
indicated that Shigella species expressed many 
OMPs of various molecular weights, including 
OMPX, OMPA, OMPT, OMPLA, TOLC, α-
hemolysin, porin OMP32, FhuA, and FEPA [5]. 
 
The S. flexneri 28 kDa OMP had the 
highest hemagglutination titer (1/32). 
Hemagglutination is an indicator of the 
ability of bacteria to attach to animal 
cells, because the erythrocyte 
membrane receptor is homologous to 
the mucosal host cell surface receptors 
[21].In order to confirm that the S. 
flexneri 28 kDa OMP is an adhesion 
protein, we conducted adhesion tests. 
The results showed that the adhesion of 
S. flexneri to mouse enterocytes was 
inhibited by the S. flexneri 28 kDa OMP, 
as shown in Table 1 and Figure 3. There 
was a significant (p=0.000) correlation 
between the dose and adhesion index. 
Therefore, OMP was able to inhibit the 
attachment of S. flexneri to enterocytes. 
We conclude that the 28 kDa S. flexneri 
OMP was an adhesin protein and a 
bacterial virulence factor [10]. 
Histopathological studies have demon-
strated that inflammatory lesions in 
shigellosis are caused by the entry of 
bacteria into the upper rectum and distal 
colon. [4]. Immunization of mice with the 
49.8 kDa S. dysenteriae pili adhesion 
protein resulted in minimal colonic 
epithelial cell damage with elevated s-
IgA levels. s-IgA binds to intracellular 
enterocyte antigens, minimizing the 
destruction of epithelial cells in the 
intestinal mucosa [9]. The 49.8 kDa S. 
dysenteriae pili adhesion protein also 
protected against the movement of 
solution from the intestine to lumen in 
the MLIL model [14]. 
 
The antigen–antibody cross-reaction 
examined by Western blotting showed 
that many Shigella spp. OMPs reacted 
with the antibody against the S. flexneri 
28 kDa OMP (Figure 4). Therefore, the 
OMP antibody would be capable of 
recognizing epitopes present in the 
OMPs of all Shigella species. Antibodies 
produced against one antigen may bind 
to a different structurally related antigen, 
referred to as a cross-reaction 
[22].These results are consistent with 
another research who detected cross-
reaction between a 34 kDa OMP and 
intact cells of Shigella species. An 
antibody against the 34 kDa S. flexneri 
OMP recognized an epitope on the 
surface of S. flexneri [23]. After 
identifying the antigen–antibody 
response to Shigella OMPs, we 
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postulated that the antibody would also 
prevent the adhesion of Shigella to the 
host cell, and hence could serve as a 
candidate shigellosis vaccine against all 
Shigella species. 
 
The 34 kDa S. flexneri OMP has already 
been purified with a promising subunit 
vaccine candidate for shigellosis [11, 
23]. Our hemagglutinin assay also 
showed a positive result for a 36 kDa S. 
flexneri OMP, which may also be an 
adhesion molecule (Figure 2).Mitra et al 
found that the colonization ability of 
Shigella spp. was directly correlated with 
the hemagglutination activity in a 
suckling mouse model [24]. A recent in 
vivo study by Hamong et al. showed that 
a 49.6 kDa Helicobacter pylori 
hemagglutinin protein prevented damage 
to the stomach caused by homologous 
bacteria in mice [25]. 
 
We postulated that adhesion molecule 
epitopes are involved in protein 
hemagglutinin due to various OMPs [14]. 
This finding should be clarified before 
developing peptide vaccines based on 
molecule adhesion epitopes. 
 
CONCLUSION 
 
A 28 kDa S. flexneri OMP is identified 
here in this study as a hemagglutinin 
protein that serves as an adhesion 
protein. Antibodies against this protein 
cross-react with the OMPs of other 
Shigella species. Further research is 
needed to determine whether the 28 kDa 
S. flexneri OMP hemagglutinin adhesion 
protein can protect against colon 
epithelial cell damage and the movement 
of solution into the intestinal lumen in 
MLIL model [10]. 
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